As reported earlier, a CD44 drug delivery system based on thiolated chitosan, surface functionalized with hyaluronic acid proved to be an ideal approach for delivery of oncolytic measles virus to prostate cancer tumors. The gene discussed is CD44; the disease is Familial prostate cancer.